BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27167055)

  • 1. Clinical, Genetic, and Biochemical Characteristics of Early-Onset Diabetes in the Finnish Population.
    Huopio H; Miettinen PJ; Ilonen J; Nykänen P; Veijola R; Keskinen P; Näntö-Salonen K; Vangipurapu J; Raivo J; Stančáková A; Männistö J; Kuulasmaa T; Knip M; Otonkoski T; Laakso M
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3018-26. PubMed ID: 27167055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.
    Ziegler AG; Schmid S; Huber D; Hummel M; Bonifacio E
    JAMA; 2003 Oct; 290(13):1721-8. PubMed ID: 14519706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
    Mäkinen A; Härkönen T; Ilonen J; Knip M;
    Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of monogenic gene mutations in Japanese subjects diagnosed with type 1B diabetes between >5 and 15.1 years of age.
    Moritani M; Yokota I; Horikawa R; Urakami T; Nishii A; Kawamura T; Kikuchi N; Kikuchi T; Ogata T; Sugihara S; Amemiya S;
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1047-54. PubMed ID: 27398945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register.
    Harsunen M; Kettunen JLT; Härkönen T; Dwivedi O; Lehtovirta M; Vähäsalo P; Veijola R; Ilonen J; Miettinen PJ; Knip M; Tuomi T
    Diabetologia; 2023 Mar; 66(3):438-449. PubMed ID: 36418577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial exposure in infancy and subsequent appearance of type 1 diabetes mellitus-associated autoantibodies: a cohort study.
    Virtanen SM; Takkinen HM; Nwaru BI; Kaila M; Ahonen S; Nevalainen J; Niinistö S; Siljander H; Simell O; Ilonen J; Hyöty H; Veijola R; Knip M
    JAMA Pediatr; 2014 Aug; 168(8):755-63. PubMed ID: 24957949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene.
    Gach A; Wyka K; Malecki MT; Noczynska A; Skupien J; Nazim J; Szalecki M; Bodalski J; Sieradzki J; Mlynarski W
    Diabetes Care; 2007 Aug; 30(8):2080-2. PubMed ID: 17475937
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M
    J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of initial cereal exposure in infancy and risk of islet autoimmunity.
    Norris JM; Barriga K; Klingensmith G; Hoffman M; Eisenbarth GS; Erlich HA; Rewers M
    JAMA; 2003 Oct; 290(13):1713-20. PubMed ID: 14519705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of neonatal diabetes: a United States experience.
    Støy J; Greeley SA; Paz VP; Ye H; Pastore AN; Skowron KB; Lipton RB; Cogen FR; Bell GI; Philipson LH;
    Pediatr Diabetes; 2008 Oct; 9(5):450-9. PubMed ID: 18662362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months.
    Edghill EL; Dix RJ; Flanagan SE; Bingley PJ; Hattersley AT; Ellard S; Gillespie KM
    Diabetes; 2006 Jun; 55(6):1895-8. PubMed ID: 16731860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal diabetes in a child positive for islet cell antibodies at onset and Kir6.2 activating mutation.
    Gach A; Wyka K; Pietrzak I; Wegner O; Malecki MT; Mlynarski W
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e25-7. PubMed ID: 19692135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of type 1 diabetes at onset in children: results from the French Incidence Study.
    Levy-Marchal C; Czernichow P
    Diabete Metab; 1993; 19(3):296-303. PubMed ID: 8405620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.
    Näntö-Salonen K; Kupila A; Simell S; Siljander H; Salonsaari T; Hekkala A; Korhonen S; Erkkola R; Sipilä JI; Haavisto L; Siltala M; Tuominen J; Hakalax J; Hyöty H; Ilonen J; Veijola R; Simell T; Knip M; Simell O
    Lancet; 2008 Nov; 372(9651):1746-55. PubMed ID: 18814906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation screening of INS and KCNJ11 genes in Taiwanese children with type 1B diabetic onset before the age of 5 years.
    Lo FS
    J Formos Med Assoc; 2018 Aug; 117(8):734-737. PubMed ID: 29361385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
    Massa O; Iafusco D; D'Amato E; Gloyn AL; Hattersley AT; Pasquino B; Tonini G; Dammacco F; Zanette G; Meschi F; Porzio O; Bottazzo G; Crinó A; Lorini R; Cerutti F; Vanelli M; Barbetti F;
    Hum Mutat; 2005 Jan; 25(1):22-7. PubMed ID: 15580558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes.
    Taka AM; Härkönen T; Vähäsalo P; Lempainen J; Veijola R; Ilonen J; Knip M;
    Pediatr Diabetes; 2022 Mar; 23(2):219-227. PubMed ID: 34894365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.
    Edghill EL; Flanagan SE; Patch AM; Boustred C; Parrish A; Shields B; Shepherd MH; Hussain K; Kapoor RR; Malecki M; MacDonald MJ; Støy J; Steiner DF; Philipson LH; Bell GI; ; Hattersley AT; Ellard S
    Diabetes; 2008 Apr; 57(4):1034-42. PubMed ID: 18162506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment.
    Globa E; Zelinska N; Mackay DJ; Temple KI; Houghton JA; Hattersley AT; Flanagan SE; Ellard S
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1279-86. PubMed ID: 26208381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.